Evidence map›Paper›PMID 36135648›Full record

ArticleJournal of fungi (Basel, Switzerland)2022

Compliance with the Updated BASHH Recurrent Vulvovaginal Candidiasis Guidelines Improves Patient Outcomes.

Lottie Brown, Mathilde Chamula, Sharon Weinberg, Frakinda Jbueen, Riina Rautemaa-Richardson

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. State-of-the-Art Review: Managing Vulvovaginal Candidiasis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Review
  3. Review
  4. A Comprehensive Overview ofJournal of fungi (Basel, Switzerland) · 2025
    Review
  5. Review
  6. New insights in the role ofFrontiers in microbiology · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Lottie BrownDivision of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M23 9LT, UK.ORCID 0000-0001-9896-8682
Mathilde ChamulaDepartment of Infectious Diseases, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK.
Sharon WeinbergDepartment of Infectious Diseases, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK.
Frakinda JbueenDepartment of Infectious Diseases, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK.
Riina Rautemaa-RichardsonDivision of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M23 9LT, UK.ORCID 0000-0002-1071-6040
Manchester University NHS Foundation Trust · GBGuy's and St Thomas' NHS Foundation Trust · GBUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrent vulvovaginal candidiasis (RVVC) is a debilitating, chronic condition that affects over 138 million (6%) women of reproductive age annually. We performed a retrospective audit of RVVC referrals to our tertiary care

Indexed as

antifungal suppressionazole-resistancefluconazolerecurrent vulvovaginal candidiasisvulval eczemavulval skin care

Identifiers

PMID36135648
PMCPMC9503580
OpenAlexW4293773390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.